The Incidence and Predictors of Developing Atrial Fibrillation in Patients With Inferior ST-segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention
NCT ID: NCT03854448
Last Updated: 2019-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
109 participants
OBSERVATIONAL
2019-03-31
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Diagnosis of AF in acute myocardial infarction (AMI) patients is important because it increases the risk of cardiovascular event and associated with increased in-hospital and long term rates . Atrial ischemia/infarction translates into P Q segment depression or elevation on the electrocardiogram and often associates with atrial tachyarrhythmias .
Side-branch obstruction is one of the adverse effects of PCI the location of the culprit vessel also affects the occurrence of AF in AMI Atrial arteries arise from the right coronary artery (RCA) and circumflex coronary artery (CX) and extend through the atrial myocardium to supply both chambers It is therefore conceivable that PCI of lesions located at the RCA and CX could lead to an accidental atrial branch occlusion .
Atrial myocardial ischemia secondary to atrial branches occlusion (ABO) might lead to mechanical atrial dysfunction, increased electrical vulnerability to atrial arrhythmias, and late structural remodeling .
The sino nodal (SN) artery originates from the proximal portion of the RCA in about 60% of humans Side branch occlusion of the SN artery occurring accidentally during PCI for proximal RCA lesions would provide an opportunity to produces SN dysfunction in humans. Uptill now , there have been no systematic studies concerning SN dysfunction caused by side-branch occlusion of the SN artery during PCI .
Left atrial volume seems to be a strong predictor of incident of AF , with increase in left atrial filling pressures, atrial stretch and enlargement of the chamber occur, leading to remodeling of the structure, physiologic properties, and electrical milieu of the left atrium, culminating in the development of AF
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
holter monitoring
Transthoracic Echocardiography (TTE) Left atrial ( LA) volume will be measured using standard apical two- and four-chamber views on the frame just prior to mitral valve opening and as specified by current American Society of Echocardiography guidelines (10) LA volume is indexed to body surface area. Mitral inflow velocity is obtained in the apical four-chamber view by placing a pulsed-Doppler sample volume between the tips of the mitral leaflets. Mitral annular velocity is assessed during the early phase of diastole(e=) using pulsed-wave Doppler sampling of septal mitral annular motion from the four chamber view.
24 to 48 hours Holter monitoring after 1 month after PCI
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Prior documentation of heart failure or reduced left ventricular ejection fraction \< 50%,
* Severe valvular disease ( rheumatic , sclerotic ) or secondary to AMI
* Left ventricular hypertrophy : enlargement and thickening of the walls of the ventricle
* Patients with inferior STEMI treated with intravenous thrombolysis or conservative strategy
* Patients with inferior STEMI who undergo primary PCI and associated with right ventricular or posterior infarction
* History of pulmonary embolism or COPD ( chronic obstructive pulmonary disease )
* Those with thyrotoxicosis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ahmed atef ahmed atef
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yehia Taha Kishk kishk, MD
Role: STUDY_CHAIR
Professor of cardiology department Assiut University
Mohamed Ali Mohamed Tohamy tohamy, MD
Role: STUDY_DIRECTOR
Lecturer of cardiology department Assiut University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Clinical factors associated with the development of atrial fibrillation in the year following STEMI treated by primary PCI
Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention
Acute regional left atrial ischemia causes acceleration of atrial drivers during atrial fibrillation
Atrial coronary artery occlusion during elective percutaneous coronary angioplasty
Sinus arrest caused by occlusion of the sinus node artery during percutaneous coronary intervention for lesions of the proximal right coronary artery
Left Atrial Volume: Important Risk Marker of Incident Atrial Fibrillation
Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction
Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans
Long Term Prognosis of Atrial Fibrillation in ST-Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
Left Atrial Size : Physiologic Determinants and Clinical Applications
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AF in inferior STEMI after PCI
Identifier Type: -
Identifier Source: org_study_id